CERT1 and cancer: Although COL4A3BP dysregulation has not been previously associated with EC, this protein has been proposed as an interesting therapeutic target for chemotherapy-resistant cancers due to the effect of COL4A3BP downregulation in promoting endoplasmic reticulum stress [77, 78].